3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system

D. Braida, S. Iosuè, S. Pegorini, M. Sala

Research output: Contribution to journalArticle

Abstract

The appetitive potential of i.c.v. injections of 3,4 methylenedioxymethamphetamine (MDMA), using a conditioned place preference (CPP) procedure, was investigated. In a range of doses (0.1-10 ng/rat), devoid of motor stimulation, a dose-dependent CPP was obtained. The effect of the most effective dose (10 ng/rat) was prevented by pre-treatment with the CB 1 cannabinoid (SR 141716A) [N-piperidino-5-(4-chlorophenyl) 1-(2, 4-dichloro-phenyl)-4-methyl pyrazole-3-carboxamide hydrochloride] (0.5 mg kg -1), the opioid (naloxone) (2 mg kg -1), and the serotonin 5-HT 3, tropisetron [endo-8-methyl-8-azabicyclo [3.2.1] oct-3-olindol-3-yl-carboxylate hydrochloride] (1 mg kg -1), receptor antagonists, which did not induce place conditioning on their own. SR 141716A was more efficient than naloxone and tropisetron in blocking the incentive learning supported by MDMA. These results demonstrate for the first time that i.c.v. MDMA, at very low doses, induces CPP and that endocannabinoid system may participate in this effect.

Original languageEnglish
Pages (from-to)177-182
Number of pages6
JournalPharmacological Research
Volume51
Issue number2
DOIs
Publication statusPublished - Feb 2005

Keywords

  • 5-HT antagonist
  • Ecstasy
  • Rat
  • Reward
  • SR 141716A

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of '3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system'. Together they form a unique fingerprint.

  • Cite this